Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SANDBERGS GULDSMEDJE ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   9.1% 6.6% 6.5% 4.8% 13.0% 19.0% 14.2% 14.0%   Credit score (0-100)   30 38 38 46 18 6 14 15   Credit rating   BB BBB BBB BBB BB B BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   160 220 231 291 331 51.9 0.0 0.0   EBITDA   13.7 73.8 84.2 144 97.8 51.9 0.0 0.0   EBIT   13.7 73.8 84.2 144 97.8 51.9 0.0 0.0   Pre-tax profit (PTP)   14.7 77.4 84.2 144.3 96.5 50.4 0.0 0.0   Net earnings   11.5 60.1 65.4 111.8 74.1 39.1 0.0 0.0   Pre-tax profit without non-rec. items   14.7 77.4 84.2 144 96.5 50.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   241 198 157 237 199 125 -273 -273   Interest-bearing liabilities   24.7 11.7 1.7 1.6 6.5 0.3 273 273   Balance sheet total (assets)   329 330 216 385 319 155 0.0 0.0   Net Debt   -196 -154 -45.7 -169 -313 -153 273 273     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   160 220 231 291 331 51.9 0.0 0.0   Gross profit growth   0.0% 37.4% 4.7% 26.1% 13.8% -84.3% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   329 330 216 385 319 155 0 0   Balance sheet change%   0.0% 0.5% -34.8% 78.5% -17.0% -51.5% -100.0% 0.0%   Added value   13.7 73.8 84.2 144.4 97.8 51.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.6% 33.5% 36.5% 49.6% 29.5% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.5% 23.5% 30.8% 48.1% 27.8% 21.9% 0.0% 0.0%   ROI %   5.5% 32.6% 45.7% 72.7% 44.1% 31.4% 0.0% 0.0%   ROE %   4.8% 27.4% 36.8% 56.7% 34.0% 24.1% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   73.3% 59.8% 73.0% 61.6% 62.4% 80.9% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,428.9% -208.2% -54.3% -117.3% -319.7% -294.9% 0.0% 0.0%   Gearing %   10.2% 5.9% 1.1% 0.7% 3.3% 0.2% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 6.7% 32.4% 44.6% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   2.6 1.5 1.7 1.6 2.7 5.2 0.0 0.0   Current Ratio   3.7 2.5 3.7 2.6 2.7 5.2 0.0 0.0   Cash and cash equivalent   220.9 165.2 47.4 171.1 319.4 153.4 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   241.0 197.7 157.3 236.8 199.1 125.2 -136.5 -136.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   14 74 84 144 98 52 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   14 74 84 144 98 52 0 0   EBIT / employee   14 74 84 144 98 52 0 0   Net earnings / employee   11 60 65 112 74 39 0 0